The much-anticipated Section 174 reform, now advancing through Congress, promises to restore the immediate expensing of domestic R&D costs—reversing the five-year amortization requirement imposed by the Tax Cuts and Jobs Act (TCJA) of 2017. For innovative businesses, startups, and established enterprises alike, this change could mean a signif